Assignee
ELI LILLY AND COMPANY PATENT D
US·0 granted patents·11 pending applications·0 citations·filing 2003–2006
Top patents by PatentIndex Score
11 records- 0155US2006135484A1Vesicant treatment with phenyl-thiophene type vitamin d receptor modulatorsELI LILLY AND COMPANY PATENT D·Filed 2004·Application pending·0 cites
- 0251US2009118167A1Selective Vpac2 Receptor Peptide AgonistsELI LILLY AND COMPANY PATENT D·Filed 2005·Application pending·0 cites
- 0345US2006293223A1Uses of melanocortin-3 receptor (mc3r) agonist peptidesELI LILLY AND COMPANY PATENT D·Filed 2004·Application pending·0 cites
- 0444US2006079680A1Pyrazoloazepine compounds as pharmaceutical agentsELI LILLY AND COMPANY PATENT D·Filed 2003·Application pending·0 cites
- 0543US2006167046A1Histamine h3 receptor antagonists, preparation and therapeutic usesELI LILLY AND COMPANY PATENT D·Filed 2003·Application pending·0 cites
- 0642US2007105845A1Quinolone derivativesELI LILLY AND COMPANY PATENT D·Filed 2004·Application pending·0 cites
- 0740US2006211755A13-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitorsELI LILLY AND COMPANY PATENT D·Filed 2004·Application pending·0 cites
- 0838US2007249623A11-(Indole-6-Carbonyl-D-Phenylglycinyl)-4-(1-Methylpiperidin-4-Yl)Piperazine D-TartrateELI LILLY AND COMPANY PATENT D·Filed 2005·Application pending·0 cites
- 0933US2005250684A1Method for reducing morbidity and mortality in critically ill patientsELI LILLY AND COMPANY PATENT D·Filed 2003·Application pending·0 cites
- 1033US2008207716A1Formulations and Dosing Regiment for Ppar-Alpha ModulatorsELI LILLY AND COMPANY PATENT D·Filed 2006·Application pending·0 cites
- 1131US2006167268A1Growth hormone secretagoguesELI LILLY AND COMPANY PATENT D·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ELI LILLY AND COMPANY PATENT D files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →